Human Papillomavirus
72
5
7
51
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
11 trials with published results (15%)
Research Maturity
51 completed trials (71% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.2%
3 terminated out of 72 trials
94.4%
+7.9% vs benchmark
7%
5 trials in Phase 3/4
22%
11 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (72)
Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination
Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV
Comparisons of the Effects and Clinical Outcomes of CH2 Vaginal Gel Versus Placebo on CIN1
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents
Provider Recommendation and HPV Vaccination
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening
Longitudinal HPV Pap in CIN and VAIN
Predictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples
Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females
Natural History of HPV Infection in Men: The HIM Study
Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3
Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)
The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men